16.11.2012 Views

251 286 - Biotech Bayern

251 286 - Biotech Bayern

251 286 - Biotech Bayern

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CRELUX GmbH<br />

BIOTECH DNA/PROTEIN ANALYTICS<br />

Keywords: 3 D Structural Analysis<br />

CRELUX provides fast and affordable access to co-crystal structures of your<br />

compounds in complex with their protein targets. Crystallization conditions of<br />

numerous relevant therapeutic targets have been established at CRELUX.<br />

Co-crystal structures of these targets in complex with your compounds of<br />

interest will be delivered at a fixed price with a typical turn around time of six<br />

to eight weeks.<br />

At CRELUX we do everything to protect your most important asset: compound<br />

IP. We are entirely dedicated to solving client structures and don't perform any<br />

internal screening and drug discovery activities. Please enquire to find out if<br />

structural services for your targets of interest are available from CRELUX.<br />

CRENANO GmbH<br />

BIOTECH DEVICES & REAGENTS<br />

Keywords: New Materials, Devices<br />

CRENANO GmbH has developed the JETHAMMER, a novel device for microbial<br />

disruption, water treatment and the generation of emulsions and nano particles.<br />

The technology makes use of the energies set free by hydrodynamic cavitation.<br />

Moderate hydrostatic pressure (5 to 10 bar) is used to induce controlled three<br />

dimensional zones of supercavitation that can readily be adjusted to disrupt<br />

micro organisms, crush particles down to nano metre scales and generate stable<br />

emulsions. The JETHAMMER operates in a in a flow through process allowing<br />

flow rates of up to 50m3 /h. CRENANO is the sole supplier of JETHAMMER<br />

and offers the full system engineering for the integration of the device into<br />

industrial production processes and water circuits.<br />

CRO-PHARMANET SERVICES GmbH<br />

CRO<br />

Keywords: Drug Development, Antibody, Antisense/Nucleotides, Small Molecules,<br />

Vaccines, Analysis, Clinical Research<br />

PharmaNet Development Group, a global, drug development services company,<br />

provides clinical development services including consulting, Phase I and bioequivalence<br />

clinical studies, Phase II-III clinical development programs, Phase<br />

IIIb-IV surveys, registries, and programs, as well as bioanalytical laboratory<br />

services through its subsidiaries Anapharm, Anapharm Europe, Keystone<br />

Analytical, and Taylor Technology.<br />

Contact:<br />

Sonja Knoth<br />

Am Klopferspitz 19a<br />

D-82152 Martinsried<br />

Phone: +49 (0) 89 700 760-170<br />

E-Mail: schaeffer@crelux.com<br />

Internet: www.crelux.com<br />

Contact:<br />

Sonja Knoth<br />

Am Klopferspitz 19a<br />

D-82152 Martinsried<br />

Phone: +49 (0) 89 700760170<br />

Fax: +49 (0) 89 700760222<br />

E-Mail: schaeffer@crenano.com<br />

Internet: www.creanano.com<br />

Contact:<br />

Dr. Tobias Schmidt<br />

Pionierstr. 2 / KIM<br />

D-82152 Krailling<br />

Phone: +49 (0) 89 895577-77<br />

Fax: +49 (0) 89 895577-99<br />

E-Mail: tschmidt@pharmanet.com<br />

Internet: www.pharmanet.com<br />

55

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!